NasdaqGS:MASIMedical Equipment
Is It Too Late To Consider Masimo (MASI) After A 40% Year To Date Rally?
Investors may be considering whether Masimo, at around US$178 per share, still offers value or if much of the opportunity is already reflected in the price.
The stock has posted a 40.1% return year to date and a 6.5% return over the last 12 months, with shorter term moves of 1.7% over 7 days and 1.9% over 30 days.
These returns have come alongside ongoing attention on Masimo's role in medical technology and its position in the broader healthcare sector. Recent headlines have continued to...